| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.0006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |